The S&P 500 went up by +0.2% and Nasdaq Composite was up by +0.3%. These 2 indices added to their record closing highs on Thursday (13 June 2024), but market breadth was negative and other major indices closed with losses. The Dow Jones Industrial Average fell 0.2% and the Russell 2000 settled 0.9% lower.
The underlying negative bias was driven by some stocks normal consolidation, this was followed by many stocks experiencing big...

Insider selling at Universal Health Services, especially by Executive VP Steve Filton, may worry investors. Despite some insider buying, the long-term outlook isn't very positive. High insider ownership suggests management's interests align with shareholders, but insider selling warrants caution.

The declining ROCE trend at Universal Health Services does not inspire confidence. Despite the company's reinvestment in its own business, returns are shrinking. Investors looking for a multi-bagger might want to consider other options.

The EPS decline may not reflect the business's evolution. Other metrics, like revenue growth and TSR, could be positive signs for long-term investors.

Universal Health Services is still a bargain according to the price multiple model. Its volatile share price could provide more buying opportunities. The company's optimistic future growth hasn't been fully factored into the share price yet.

Insider selling over the past year may worry shareholders, despite high insider ownership suggesting aligned interests. This activity raises doubts in the company's valuation.

Universal Health Services' trends for ROCE raise concerns due to the lack of significant sales growth or changes in earnings from investment activities. The moderate stock gain may signal investors' uncertainty on future performance.